Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
International Journal of Biometeorology|May 19, 2026
Passive cooling garments for outdoor thermal adaptation: a field experimentYasuhiro Shimazaki, Naoto Tominaga, Jihui Yuan, et al.
JCEM Case Reports|April 16, 2024
Attenuation of Bone Mineral Density Decline During Anemia Treatment With Methenolone Acetate in Myelodysplastic SyndromeShu Ushimaru, Hirofumi Sumi, Mea Aso, et al.
Plos One|September 22, 2018
Hyponatremia and the risk of kidney stones: A matched case-control study in a large U.S. health systemNaoto Tominaga, Stephen J Fernandez, Mihriye Mete, et al.
Internal Medicine (Tokyo, Japan)|February 11, 2026
Invasive Pneumococcal Disease Presenting with Pyogenic Spondylitis in a Patient on Chronic Hemodialysis Who Previously Received a Pneumococcal Vaccine: A Case ReportMari Arakawa, Yoko Fujita, Yuki Yokokawa, et al.
Case Reports in Nephrology|August 16, 2016
Aldosterone Response in Severe Hypokalemia and Volume Depletion: A Case Report and Review of the Recent ResearchKeiko Kai, Naoto Tominaga, Daisuke Uchida, et al.
Dalton Transactions (Cambridge, England : 2003)|February 20, 2019
Hexavacant γ-Dawson-type phosphotungstates supporting an edge-sharing bis(square-pyramidal) {O2M(μ3-O)2(μ-OAc)MO2} core (M = Mn2+, Co2+, Ni2+, Cu2+, or Zn2+)Kosuke Suzuki, Takuo Minato, Naoto Tominaga, et al.
Clinical and Experimental Nephrology|June 24, 2018
Comparison of the effects of tolvaptan and furosemide on renal water and sodium excretion in patients with heart failure and advanced chronic kidney disease: a subanalysis of the K-STAR studyNaoto Tominaga, Keisuke Kida, Takayuki Inomata, et al.
American Journal of Nephrology|November 14, 2017
Effects of Tolvaptan Addition to Furosemide in Normo- and Hyponatremia Patients with Heart Failure and Chronic Kidney Disease Stages G3b-5: A Subanalysis of the K-STAR StudyNaoto Tominaga, Keisuke Kida, Takayuki Inomata, et al.
Clinical Nephrology|May 23, 2015
Safety of add-on tolvaptan in patients with furosemide-resistant congestive heart failure complicated by advanced chronic kidney disease: a sub-analysis of a pharmacokinetics/ pharmacodynamics studyNaoto Tominaga, Keisuke Kida, Naoki Matsumoto, et al.
Clinical Pharmacokinetics|October 12, 2014
Efficacy of tolvaptan added to furosemide in heart failure patients with advanced kidney dysfunction: a pharmacokinetic and pharmacodynamic studyKeisuke Kida, Yugo Shibagaki, Naoto Tominaga, et al.
Pageof 3